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Abstract
Objective. To examine the efficacy of the modified Story Memory Technique (mSMT) to improve learning (ie, acquisition)
and memory in participants with TBI. The mSMT is a behavioral intervention that teaches context and imagery to facilitate
learning within 10 sessions over 5 weeks. Methods. A total of 69 participants with moderate-severe Traumatic Brain Injury
(TBI), 35 in the treatment group and 34 in the placebo control group, completed this double-blind, placebo-controlled
randomized clinical trial. A baseline neuropsychological assessment was administered, including questionnaires assessing
everyday memory. Repeat assessments were conducted immediately posttreatment and 6 months following treatment.
Participants in the treatment group were randomly assigned to a booster session or a non–booster session group after
completion of treatment with the mSMT to examine the efficacy of monthly booster sessions in facilitating the treatment
effect over time. Results. The treatment group demonstrated significant improvement on a prose memory task relative to
the placebo group posttreatment (η2 = 0.064 medium effect). Similar results were noted on objective measures of everyday
memory, specifically prospective memory (Cohen’s w = 0.43, medium effect), and family report of disinhibition in daily life
(η2 = 0.046, medium effect). Conclusion. The mSMT is effective for improving learning and memory in TBI. Classification of
evidence. Based on widely accepted classification systems for treatment study design, this study provides class I evidence
that the mSMT behavioral intervention improves both objective memory and everyday memory in persons with TBI over
5 weeks. Thus, this study extends the evidence for efficacy of the treatment protocol to a sample of persons with TBI.
Keywords
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Approximately 1.6 million Americans sustain a TBI each
year,1 with cognitive impairment being a common concomitant.2 Cognitive dysfunction may affect attention,3 information
processing abilities,4 language skills, executive functions,
learning and memory.4,5 Memory is one of the most frequently
impaired functions identified in this population,2,6-8 with current prevalence rates ranging from 54% to 84%.4 Such deficits
have been shown to exert a significant negative impact on multiple aspects of everyday life, including occupational, emotional, and social functioning, and is a major cause of disability
among these individuals.9,10 In fact, deficits in learning and
memory functioning are a major factor in one’s ability to maintain meaningful employment after TBI.4 As a result, virtually
all intensive TBI rehabilitation programs include some form of
cognitive intervention to minimize the impact of these deficits
on daily life.9,11
Despite the fact that previous studies have examined the
efficacy of cognitive rehabilitation, much of this research is
lacking in methodological rigor. Specifically, Cicerone and
colleagues have conducted several critical reviews of the literature,9,11,12 only reporting 10 prospective, randomized clinical

trials for memory rehabilitation. These studies examined protocols utilizing external assistive devices/aids,13-15 memory strategy applications,16-18 mnemonics, rehearsal and visual imagery
training,19,20 and computer-based memory software.21,22
Although modest treatment effects were reported, the magnitude of the treatment effects observed and the long-term efficacy of the treatment were difficult to determine.
Memory deficits may be a result of difficulty in multiple
aspects of the memory process.6,23-25 Previous research in our
laboratory has shown that individuals with TBI have difficulty
learning, that is, acquiring new information (defined as encoding + consolidation). Specifically, participants with TBI require
significantly more learning trials than healthy participants to
learn the same amount of information. However, once equated
1
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Table 1. Demographic and Disease Characteristics by Treatment Group.
Treatment (n = 35)
Age (in years)
Education (in years)
Months since injury
Glasgow Coma Scale
Trials to reach criterion
WASIb vocabulary T score
(premorbid IQ)
Percentage male

37.17 (11.24)
13.00 (1.93)
119.97 (128.91)
4.83 (3.19)
13.94 (3.19)
43.06 (11.71)

Control (n = 34)

Test Statistic (t Value Unless Otherwise Indicated)

40.68 (11.28)
14.25 (1.82)
101.97 (70.78)
5.0 (2.51)
13.24 (3.04)
43.29 (11.25)

1.07
2.77a
−0.722
0.124
−0.943
−0.085

71%

χ2 = 0.384

77%

a

P < .01.
Wechsler Abbreviated Scale of Intelligence: a screening tool of verbal and nonverbal cognitive abilities consisting of 4 subtests of the Wechsler Adult
Intelligence Scale-IV (Vocabulary, Similarities, Block Design, Matrix Reasoning).
b

on the amount of information initially learned, individuals with
TBI do not demonstrate deficits in recall or recognition.24
Given that the memory deficit in TBI is primarily one of learning new information, an effective cognitive remediation program must target new learning abilities.
Context and imagery have been demonstrated to be
effective in improving learning and memory in healthy controls26,27 and samples of TBI patients.20,28-30 The current
study was designed to extend the evidence for efficacy of
the modified Story Memory Technique (mSMT31,32) to a
sample of people with TBI. This treatment protocol was
specifically designed to remedy deficits in new learning and
memory functioning utilizing the strategies of context and
imagery. The mSMT is a 10-session behavioral treatment
protocol designed to teach the patient to use context and
imagery to facilitate learning. Several studies now demonstrate the efficacy of the mSMT in other neurological populations. For example, research from our lab has demonstrated
that the mSMT improves new learning and memory abilities, as determined by a neuropsychological evaluation, as
well as everyday life activity in persons with multiple sclerosis (MS).31,32 In addition, work from our lab has demonstrated that relative to placebo controls, MS participants in
the treatment group showed increased cerebral activation33
and increased connectivity34 while performing a memory
task posttreatment using fMRI within a widespread cortical
network involving frontal, parietal, precuneus, and parahippocampal regions. The increased activation seen likely
reflects increased application of strategies taught during the
mSMT when learning new information.33
The current study was designed to examine the efficacy
of the mSMT in a large sample of persons with TBI. The
primary hypothesis was that participants with TBI in the
treatment group with documented learning and memory
impairment will demonstrate significant improvement on
standardized neuropsychological (NP) memory tasks following the 10-session memory retraining with the mSMT relative to placebo controls. Secondary hypotheses were the

following: (1) Improvement in learning and memory functioning in the treatment group will also be noted on objective
measures of everyday memory, specifically the Rivermead
Behavioural Memory Test (RBMT); such changes will not be
evident in the TBI placebo control group; (2) compared with
persons in the placebo-control group, persons in the treatment group will show decreased cognitive symptoms in daily
life on the self-report and family report of the Frontal Systems
Behavior Scale (FrSBe); and (3) based on previous work
demonstrating an improvement in emotional symptomatology following cognitive rehabilitation in multiple neurological populations,35-41 we hypothesized that depression and
anxiety levels will decrease following participation in the
mSMT in the treatment group but not the placebo control
group. It was additionally expected that participants with TBI
will continue to demonstrate improvement in their new learning abilities up to 6 months following treatment and that
booster sessions would result in significantly better longterm treatment effects.

Method
Participants
A total of 69 participants (treatment, n = 35; control, n = 34)
were recruited from local TBI clinics, study advertisements
published in consumer newsletters and distributed at support groups, through the Northern NJ TBI Model System,
and through the Kessler Foundation database of research
participants. There were no significant differences between
the groups in age, gender, estimated premorbid verbal IQ,
baseline learning ability, or time since injury (Table 1). The
control group had significantly greater years of education:
t(63) = 2.68; P < .01. The groups performed similarly on
tests of NP functioning prior to treatment as well as reports
of both depression and anxiety (Table 2). Verification of
health status, date of injury, and duration of loss of consciousness was achieved via medical record review.
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Table 2. Neuropsychological Test Performance by Treatment Group at Baseline.
Variable
Attention
Digit Span Scaled Score
Working Memory
Letter Number Sequencing Scaled Score
PASAT: trial 1, z score
PASAT: trial 2, z score
PASAT: trial 3, z score
PASAT: trial 4, z score
Processing speed
SDMT z score
Executive functioning
Trail making, visual scanning scaled score
Trail making number sequencing scaled score
Trail making letter sequencing scaled score
Trail making switching scaled score
Verbal fluency letter scaled score
Verbal fluency category scaled score
Verbal fluency switching scaled score
Color-word word reading scaled score
Color word color naming scaled score
Color word interference scaled score
Tower achievement scaled score
Intelligence
WASI vocabulary scaled score
WASI block design scaled score
WASI similarities scaled score
WASI matrix reasoning scaled score
Learning and memory
OT-SRT trials to criterion raw score
CVLT total learning T score
CVLT learning slope T1-5 z score
MAS prose memory immediate recall (raw)
MAS prose memory delayed recall (raw)
Everyday memory
FrSBe disinhibition after illness (family), T score
FrSBe apathy after illness (family), T score
 FrSBe executive dysfunction after illness (family),
T score
FrSBe total after illness (family), T score
Emotional functioning
State anxiety, T score
Trait anxiety, T score
 Chicago multidimensional depression inventory,
T score

Treatment Group, n = 35 Control Group, n = 34

Test Statistica

8.44 (1.58)

8.41 (2.63)

−0.056

8.38 (2.53)
−1.44 (1.21)
−1.55 (1.13)
−0.98 (.89)
−0.75 (.87)

8.82 (2.99)
−1.79 (1.20)
−1.21 (1.14)
−0.96 (.77)
−0.74 (.80)

−0.656
1.15
1.19
−0.118
0.06

−2.04 (1.21)

−2.09 (1.41)

−0.149

5.97 (3.55)
6.10 (4.32)
6.34 (4.35)
5.52 (4.31)
7.58 (3.19)
7.45 (3.53)
5.88 (3.90)
5.27 (3.67)
5.39 (3.65)
6.48 (3.99)
8.68 (3.31)

5.79 (3.86)
6.42 (4.49)
6.12 (4.67)
6.70 (4.27)
8.24 (3.29)
8.06 (3.89)
7.09 (4.06)
5.65 (3.84)
6.09 (3.93)
7.94 (4.00)
9.61 (3.20)

−0.188
0.286
−0.194
1.08
0.833
0.665
1.24
0.749
0.408
1.49
1.11

7.71 (3.66)
7.93 (3.28)
8.76 (3.90)
9.09 (3.99)

7.88 (3.40)
8.39 (3.26)
8.62 (3.66)
9.79 (3.72)

0.206
0.556
−0.160
0.755

13.94 (3.19)
37.32 (12.16)
0.82 (1.09)
9.00 (4.09)
7.03 (3.79)

13.24 (3.04)
40.38 (13.96)
−0.71 (1.29)
9.82 (3.73)
8.94 (4.18)

−0.943
0.963
0.405
0.868
1.98

50.0 (15.56)
69.12 (18.92)
67.35 (17.35)

46.86 (9.07)
64.62 (15.12)
67.00 (11.77)

−0.778
−0.815
−0.075

67.24 (19.51)

67.43 (13.81)

0.036

49.06 (12.99)
53.90 (14.71)
51. 25 (18.75)

50.97 (14.0)
57.06 (18.23)
54.73 (16.98)

0.555
0.751
0.766

Abbreviations: CVLT, California Verbal Learning Test; FrSBe, Frontal Systems Behavior Scale; MAS, Memory Assessment Scale; OT-SRT, Open Trial
Selective Reminding Test; PASAT, Paced Auditory Serial Addition Test; WASI, Wechsler Abbreviated Scale of Intelligence; SDMT, Symbol Digit
Modalities Test.
a
All comparisons are nonsignificant.

Inclusion Criteria
Objective evidence of impaired new learning (ie, acquisition)
and memory was required for participation, defined as

performance 1.5 standard deviations or greater below the mean
of a healthy group on the Open Trial Selective Reminding Test
(OT-SRT42). The OT-SRT is a list learning task in which the
examiner reads a list of 10 semantically related words on trial 1,
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and the participant recalls as many words as possible. On the
remaining trials, the examiner reminds the participants of only
the words he or she did not recall on the previous trial. This
procedure continues until all 10 words have been recalled correctly on 2 consecutive trials or a maximum of 15 learning trials
were completed. Only individuals requiring 8 or more trials to
reach the learning criterion were included. Participants were 18
to 59 years of age, 1 year postinjury and demonstrated ability to
follow 1, 2, and 3 step commands on the Token Test.43

Exclusion Criteria
Potential participants were excluded if they had (1) neurological history besides TBI; (2) uncontrolled seizures; (3)
hydrocephalus; (4) current steroid and/or benzodiazepine
use (medications reflecting standard of care in TBI were not
excluded; however, dosages were monitored for stability
throughout participation); (5) history of diagnosed major
depressive disorder, schizophrenia, bipolar disorder; (6)
history of a diagnosed substance use or dependence disorder (including alcohol); (7) evidence of significant vision
impairment from diplopia, nystagmus, or scotomas on testing (corrected vision in worse eye >20/60).
Power. Based on our pilot study of the mSMT in MS,31 we
expected a 10% increase in performance on a verbal learning
test following treatment in a sample with moderately impaired
new learning. This is a modest estimation of effect size when
applying the technique to a sample of TBI patients, given that
a previous study40 found a large effect size with a similar cognitive intervention in TBI. A repeated-measures design was
used in which both the experimental and control groups were
assessed 3 times on the California Verbal Learning Test
(CVLT), a 16-item list learning test commonly used in neuropsychological assessment, with alternate forms: baseline,
postintervention, and follow-up. Given previous research on
this measure in TBI, we expect the mean CVLT total learning
to be roughly T = 36 (SD = 10)44 in our sample of TBI
patients. With analysis of covariance (ANCOVA) as the primary method for examining group differences following
treatment, a hypothesized 10% increase in CVLT from baseline to immediate follow-up, and significance set at .05 for a
nondirectional test, only 30 participants per group were
needed to achieve power of 0.80.

Design
This RCT used a 5-week, double-blind, parallel-groups
design. Potential participants underwent a 2-part screening
prior to enrollment, consisting of an initial telephone screen
for age, injury type and date, neurological history, and current medications and an in-person screening for psychiatric
and substance abuse history, visual acuity, language comprehension, and learning and memory.
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The groups were assigned via 1:1 randomization using
a computerized random number generator. Treatment
allocation was concealed. The individual responsible for
group assignment was not otherwise involved in data collection, and group assignment was verified by a second
individual via a duplicate copy of the randomization table
generated before the initiation of data collection. Only the
person administering treatment was aware of group assignment. All other study personnel were blinded, which was
ensured through several mechanisms. First, therapists and
evaluators were always different. Second, therapists and
evaluators were not able to communicate directly about participants; all communication occurred through the study
coordinator. Participants were blinded to group assignment
and consented to participate in a study examining the impact
of mental exercises on memory. Participants were informed
that they had a 50% chance of being assigned to the treatment or control groups. To evaluate the integrity of blinding, participants completed a questionnaire following
participation, with 48% responding with the correct group
assignment (chance response rate).
Once qualifying for participation, participants underwent baseline evaluation, including NP assessment and
questionnaires assessing the impact of cognition on daily
life. The NP was performed in one session, and tests were
administered in a standard order for all participants.
Within 1 week of completing treatment, participants completed the same evaluation procedures with alternate forms
(immediate follow-up). The treatment group was further randomized into active- or placebo-booster session groups to
examine the efficacy of monthly booster sessions to increase
maintenance of treatment over time. The randomization
method was exactly the same as for treatment group assignment; 1:1 randomization was utilized via a computerized random number generator. Long-term follow-up was then
conducted with all participants 6 months following treatment
completion. The same evaluator conducted baseline, immediate, and long-term follow-up evaluations wherever possible.
All evaluators completed a comprehensive training program
prior to receiving approval to conduct NP assessments. This
training is standard procedure in our lab and consists of oneon-one training with the lab research coordinator, who has 15
years of experience with NP assessment and cognitive rehabilitation. Training consists of initial presentation of each test
individually, guided practice, individual practice with mock
participants, and evaluation by the research coordinator. Once
approved for testing by the research coordinator, the evaluator
must receive a second level of approval from a PhD-level
neuropsychologist.

Treatment Protocol
As with assessment procedures, the person administering
the treatment protocol was always different from the person
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conducting the evaluations, to maintain blinding. Training
procedures in conducting both treatment and control sessions are tightly based on training procedures for NP testing, consisting of initial presentation of each treatment
session, guided practice, individual practice with mock participants, and evaluation by the research coordinator. Again,
once approved for testing by the research coordinator, the
evaluator must receive a second level of approval from a
PhD level Neuropsychologist.
Treatment Group. The mSMT31 consists of 10 one-on-one
treatment sessions occurring twice per week for 5 weeks,
lasting 45 to 60 minutes each. Two skills were trained. (1)
In sessions 1 to 4, participants were taught to utilize imagery to facilitate learning. This was accomplished through
the participants reading stories for which they were
instructed to remember the target words and taught to utilize mental imagery to increase their memory for this information. (2) In sessions 5 to 8, participants learned to utilize
context to facilitate learning. This was done through the use
of word lists, for which the participant was taught to first
create a highly visualizable story from the list of words and
then apply their newly acquired imagery skills to visualize
that story. Sessions 9 to 10 focused on generalization to
everyday life; participants were taught to apply the mSMT
to real-world memory-demanding tasks, utilizing both context and imagery to remember the information. The treatment is highly manualized, and scripts are provided for the
therapist to follow.
Placebo Control. The placebo condition controlled for professional contact and the impact of being in a treatment program. Participants met individually with the therapist at the
same frequency as the treatment group, engaging in non–
training-oriented tasks. Non–training-oriented tasks consisted of reading the same stories that the treatment groups
read and answering questions about their content. The placebo and treatment groups were matched for duration of
contact with the examiner and computer presentation of all
material. Only the treatment group received the active
ingredients of the training (imagery and context).
Booster Sessions. Participants assigned to the booster session condition received monthly sessions similar to training
sessions 9 to 10, focused on applying the mSMT to realworld situations. The booster session control group completed the control sessions from the treatment arm of the
study. That is, they completed non–training-oriented tasks
that consisted of reading the same stories that the treatment
groups read and answering questions about their content.
Thus, the active and control booster session groups were
comparable in everything except for the active ingredients
of context and imagery.

Outcome Measures
Coprimary outcomes consisted of 2 NP memory tests: (1)
Memory Assessment Scales, Prose Memory (MAS-PM)45
and (2) the CVLT-II learning slope.46 MAS-PM examines
the ability to learn preorganized verbal information. This
test presents a 60-word story about a robbery for immediate
and delayed free recall. A parallel form was used for the
immediate follow-up. MAS-PM is a valid and reliable measure with excellent test-retest reliability (r = 0.89-0.91).45
This test was administered to examine changes in paragraph
memory from before to after treatment, which would presumably improve with increased visual imagery applied to
learning.
The CVLT examines the ability to learn unorganized
verbal information. Administration consists of learning a
list of 16 words from 4 semantic categories presented orally
over 5 trials. Two alternate forms minimize carryover
between testing sessions. The CVLT I was used as the third
form at long-term follow-up. The CVLT I and II are highly
correlated.46 The dependent variable was the CVLT learning slope across the 5 learning trials. This measure was
selected because of its ability to capture the rate of learning
over 5 repetitions of the word list. It is this learning ability
that the mSMT targets through the application of context
and imagery to learn new verbal information, including
both lists of words and paragraphs.
Secondary outcomes consisted of (1) an objective evaluation of everyday memory (RBMT), (2) participants’ subjective report of overall functioning and behavioral
symptoms associated with cognitive changes in neurological injuries, and (3) significant others’ report of the same
cognitive and functional changes.
The RBMT includes memory tasks directly related to
everyday aspects of memory functioning, such as practical
tasks of remembering a name-photograph association, a
hidden belonging, an appointment, a story, faces, and a
novel route. Four parallel forms are available; forms A to C
were utilized in consecutive order. The RBMT demonstrates good internal consistency, reliability,47 and construct
validity.48 The RBMT was administered to provide a measure of memory performance on daily life activities.
The FrSBE assesses behaviors associated with neurological illness/injury, with an emphasis on those symptoms
associated with the frontal lobes.49 It consists of 46 items
rated on a 5-point scale for 2 time points, before and after
the injury, during the 2 weeks prior to testing. Three subscale scores (apathy, disinhibition, and executive dysfunction) comprise the total score. Patient and informant ratings
are obtained. Dependent variables were the 4 indices after
the injury for self-report and informant report. We chose to
administer the FrSBe for several reasons. First, the FrSBe is
a measure that has been recommended for use as an
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outcome measure in TBI research.50 Second, Karzmark et
al51 reported that the informant version of the FrSBe is a
better predictor of daily life functioning than using neuropsychological tests alone in a mixed neurological sample,
including individuals with TBI. Reid-Arndt et al52 further
noted that the FrSBe more strongly correlated with measurement of community reentry than neuropsychological
tests of executive functioning. Additionally, despite the fact
that it was designed as an assessment of executive functioning, it queries the patient and informant about many aspects
of daily life that require everyday memory skills (eg, mix up
a sequence, get confused when doing several things in a
row; make the same mistakes over and over, do not learn
from past experience; forget to do things but then remember
when prompted or when it is too late; use strategies to
remember important things). Finally, the FrSBe is included
in the NIHI Common Data Elements and is thus recommended as an outcome measure in clinical trials.53
The State Trait Anxiety Inventory and Chicago Multidimensional Depression Inventory examined changes in
emotional functioning following treatment. Changes in
emotional functioning have been noted previously following cognitive rehabilitation.35-41

Statistical Analyses
All participants were included in the analysis per the intendto-treat design. Data imputation was done via carryover of
the most recent testing results. Specifically, 4 participants
discontinued participation during the treatment phase (2
treatment and 2 control). Thus, their baseline scores were carried forward to the immediate and long-term follow-up
assessments, conservatively estimating no change from baseline scores. Between the immediate and long-term follow-up,
12 participants discontinued participation. Thus, their scores
from the immediate follow-up were carried forward to the
long-term follow-up. A follow-up sensitivity analysis, utilizing the mean of all participants as the imputed value for each
dependent variable (DV), demonstrated similar results.
Analysis examining treatment effects utilized an ANCOVA,
with baseline performance and education serving as the
covariate in each analysis. All analyses were conducted
using raw scores. Data were analyzed with 1-tailed tests
because our hypotheses were unidirectional, with no reason to expect that participants would show a decline in
performance within a 5-week trial. This approach has been
recommended by Ludbrook,54 who stated that unidirectional tests are preferred to test directional hypotheses
when H1 is specified a priori. Because of the designation
of coprimary outcome measures, α was reduced to .025 for
these analyses. Repeated-measures ANOVA were used to
examine long-term treatment effects. Analyses were performed with SPSS version 18 software. No interim data
analyses were performed.
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Ethics and Registration
All procedures were approved by an institutional review
board, and all participants provided written informed
consent. The RCT is registered with clinicaltrials.gov
(NCT01207375).

Results
Recruitment ran from September 2007 to September 2013,
with follow-ups completed in June 2014. The trial ended
with completion of external funding. A total of 69 participants with documented moderate to severe TBI were randomly assigned to the treatment (n = 35) or placebo-control
group (n = 34). Four participants dropped out of the study
between baseline and immediate follow-up (2 from the
treatment group and 2 from the control group; 6% attrition).
Also, 12 more participants dropped out of the study between
immediate and long-term follow-up (9 from the treatment
group and 3 from the control group), resulting in a slightly
higher attrition rate at this stage (19%). Participants discontinued treatment because of the time commitment and moving out of the geographical region. Analysis was based on
an intend-to-treat population (Figure 1), as described in the
analyses section.

Treatment Efficacy
Objective NP Performance. There were no significant differences between the groups at baseline on any of the neuropsychological tasks (Table 2).
After controlling for the variance associated with
baseline performance on MAS-PM—delayed as well as
education—the treatment group showed a significant improvement in prose recall from baseline to follow-up in comparison to the placebo group: F(1, 69) = 4.45, P < .025 1-tailed,
partial η2 = 0.064 medium effect; CI = −1.71 to −0.047;
Figure 2. The MAS-PM-delayed at baseline [F(1, 69) =
37.28; P < .001; partial η2 = 0.365 large effect] was a significant covariate in the model, whereas education was not
[F(1, 69) = 0.046; NS; partial η2 = 0.001 small effect]. No
significant treatment effect was noted on the CVLT learning
slope [F(1, 69) = 0.686, NS, η2 = 0.011 small effect; CI =
−0.154 to 0.373].
To examine the percentages of participants who benefitted
from treatment versus those who did not, a χ2 analysis was conducted. With benefit defined as a 10% or greater improvement
on the MAS-PM from baseline to immediate follow-up (consistent with studies of pharmacological agents determined to
improve cognition in neurological samples55), 49% of participants in the treatment group showed an improvement compared with only 18% of the control group: χ2(1) = 7.42, P =
.006, Cohen’s w = 0.33, medium effect; Figure 2). We also
computed the reliable change index using the Jacobson-Truax56
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Figure 1. Participant flow.

Abbreviations: mSMT, modified Story Memory Technique; OT-SRT, Open Trial Selective Reminding Test; TBI, traumatic brain injury.
Note: Color version of the figure is present with the online version of this issue at www.nnr.sagepub.com

formula and a 0.90 confidence interval (a 95% chance of true
improvement for participants surpassing this threshold) to
determine the percentage of participants in the treatment group
who positively benefited57 from treatment. In all, 23% of the
treatment group showed a reliable positive change following
treatment, compared with only 9% of the control group.
Objective Everyday Memory. A greater percentage of participants in the treatment group demonstrated improvement on
the RBMT hidden belonging task at immediate follow-up
versus the placebo group: χ2(2) = 7.36, P = .025, Cohen’s
w = 0.43; Figure 3. No other significant differences were
noted on the RBMT.

Subjective Everyday Cognition and Emotion. On the FrSBe,
informants reported an improvement in disinhibition from
before to after treatment in the treatment group, with no difference noted in the placebo group: ANCOVA F(1, 31) =
6.86, P < .05; η2 = 0.046, medium effect; CI = 0.738 to
6.04). There was no significant difference between the
groups at baseline (Table 2). No significant differences
were noted from pretreatment to posttreatment between
groups on the patient report forms.
There were no significant differences between the groups
for depression [F(1, 61) = 0.024; P = NS; η2 = 0, no effect; CI =
−12.62 to 14.72] or anxiety [F(1, 57) = .075, P = NS; η2 = 0, no
effect; CI = −4.63 to 4.86] from before to after treatment.
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70%

53%

35%

18%

0%
Treatment

Control

Figure 2. Percentage of participants who improve on Prose Memory Immediate from pretreatment to posttreatment, by group.
Error bars are 1 standard error. p=.006

50%

38%

TREATMENT
CONTROL

25%

13%

0%
RBMT Belonging

Figure 3. Percentage of participants showing improvement on Rivermead Behavioural Memory Test (RBMT) hidden belonging task
posttreatment, by group. p=.025
Note: Color version of the figure is present with the online version of this issue at www.nnr.sagepub.com

Long-Term Effects
Long-term maintenance of treatment for MAS-PM Delayed
was analyzed by a 2 (Group: treatment vs control) × 2
(Follow-up: immediate vs 6 months) Repeated Measures
(RM) ANOVA with baseline and education included as
covariates. The main effects of Group [F(1, 65) = 1.85, P =
NS; partial η2 = 0.028] and Follow-up [F(1, 65) = 0.33, P =
NS; η2 = 0.005] were not significant. The interaction Group
× Follow-up, however, was significant [F(1, 65) = 3.924, P
= .052; η2 = 0.057], indicating that the 2 groups performed
similarly again after the passage of 6 months.

The 6-month follow-up data for the FrSBe could not
be analyzed because of the fact that only 30 participants
returned the FrSBe informant form at the 6-month
follow-up.

Booster Sessions
Booster session efficacy was analyzed by a 2 (Group:
booster vs nonbooster) × 2 (Follow-up interval: immediate
vs 6 months) RM ANOVA. On the MAS-PM Delayed
Recall, neither the main effects of Group [F(1, 31) = 0.047;
P = NS; partial η2 = 0.002] nor Follow-up [F(1, 31) = 0.186;
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P = NS; partial η2 = 0.006] nor the interaction Group ×
Follow-up [F(1, 31) = 0.428; P = NS; partial η2 = 0.014]
were significant. No adverse or unintended effects of the
treatment were noted in any participant.

Discussion
This study provides class I evidence supporting the efficacy of a behavioral memory rehabilitation program for
TBI patients, the mSMT. The present trial was based on
the finding that impaired memory performance in TBI is
primarily a result of impaired initial learning (ie, acquisition).24 Rehabilitation interventions should, thus, focus on
improving the learning deficit to achieve maximal benefit.
Evidence has accumulated supporting the efficacy of context and imagery to strengthen learning/acquisition (learning includes the memory processes of encoding and
consolidation), resulting in significantly improved retention.30,38-41,58,59 The current results increase that evidence,
demonstrating that training in context and imagery results
in significant improvements in verbal learning. Behavioral
interventions that specifically target strengthening the
acquisition (ie, encoding and consolidation) of information
during initial learning can significantly improve memory
performance in TBI patients.
Treatment with the mSMT had a positive impact on NP
memory tests and measures of everyday functioning. The
impact of treatment on the memory tests revealed improvement on the paragraph memory task but not on the list learning
task. These 2 tests likely rely on different cognitive processes.
That is, to-be-remembered information in the paragraph learning task was preorganized for the participant, whereas to-beremembered information on the list learning task was
disorganized. The list learning task thus requires the participant to organize the information as an initial step during learning. The critical difference between these 2 memory tasks is
this requirement of organizational skills. The treatment effect
was observed only on the task that did not require organization.
The mSMT teaches participants to apply context (or organization) and imagery techniques to facilitate stronger and deeper
memory acquisition and improve learning. The divergent pattern of results implies that participants with TBI in the current
study successfully applied the imagery component of the
mSMT to learn the preorganized paragraph task, but they did
not successfully apply context learned in the mSMT to effectively learn the disorganized list. This pattern of results differs
from that observed in MS samples32 where participants were
able to utilize both imagery and context to facilitate the acquisition of new information into memory. It is important to note
that those with severe learning difficulties in TBI12,24 and other
populations, including those with stroke,60 frontotemporal
dementia,61 and amnesia,62 often show related deficits in executive control (including organizational abilities). Others have
shown that the presence of significant executive dysfunction
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limits the effectiveness of interventions for severe memory
deficits.12
It is important to note that the treatment effect observed on
the NP learning and memory tests extended to an objective test
of everyday memory (RBMT) and informant-reported
improvements in disinhibition in daily life. The improvements
in cognition resulting from treatment with the mSMT are thus
associated with improvements in everyday function, truly
affecting the patient’s daily life. Of note, the RBMT has multiple subscales, including general orientation questions and
facial recognition. The positive effect of treatment was not
notable on all subscales of the RBMT. Given the nature of the
mSMT instructions, it may be unreasonable to expect treatment to benefit all aspects of everyday memory. It will be necessary for future work to continue to demonstrate how the
mSMT treatment generalizes to different tests of everyday
memory and how these tests relate to functioning in daily life.
Interestingly, the change in daily life reported by informants
was noted on the informant disinhibition subtest of the FrSBe.
Although one would not have instinctively expected to detect
such a change on a disinhibition measure, recent literature
points to the relationship between the Informant Disinhibition
Scale of the FrSBe and daily life functioning. Specifically,
Karzmark et al51 noted that whereas all the subscales correlated
with daily activities, the correlation between the informant
FrSBe, Disinhibition Scale, and the Functional Activities
Questionnaire was higher (r = 0.36; P < .05). Furthermore,
when the FrSBe Informant Disinhibition Scale was included in
a regression predicting the Functional Activities Questionnaire,
the informant Disinhibition subscale accounted for 7% variance over and above that which was accounted for by neuropsychological assessment. It is, thus, likely that the FrSBe
Informant Disinhibition Scale is tapping into an aspect of
everyday functioning that is uniquely affected by this mSMT
and particularly salient to the informants.
At the 6-month follow-up, the 2 groups were found to
again perform similarly on the paragraph learning task.
Despite the fact that booster sessions were incorporated into
the study protocol to help maintain the treatment effect over
time, no effect of booster sessions in maintaining the treatment effect over time was noted. This contrasts with previous work in normal aging demonstrating that booster
sessions can be effective in maintaining a treatment effect
over time.63 Potential explanations for this include small
sample size (underpowered for this analysis) and less-thanoptimal frequency, intensity, or content of the booster sessions. For example, effective booster sessions might focus
on the actual skills taught in treatment, with refreshers provided on context and imagery, rather than the practice of
applying context and imagery to daily life. The ideal content of and frequency of booster sessions is an important
topic for future investigations in an effort to facilitate the
maintenance of posttreatment gains in memory abilities
over time.
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Increasing efforts have been directed toward developing
effective memory rehabilitation treatments in TBI.9,11,12,64
These treatments can be classified as either compensatory or
restorative.12 The accumulating evidence seems to support the
efficacy of compensatory strategies over restorative strategies,64 although additional research into the efficacy of restorative strategies is necessary before making absolute claims
about the effectiveness of such treatments. Compensatory
approaches can be further decomposed into internal and external memory training strategies, that is, utilizing new mnemonic techniques or utilizing peripheral memory aids (eg, a
notebook), respectively.65 Compensatory strategy training
has been recommended as a clinical practice standard for
treating memory impairment in TBI.12 The present evidence
suggests that the mSMT is a valuable compensatory-internal memory rehabilitation strategy that should be incorporated into the clinical practice standards for treating memory
impairment associated with TBI. Furthermore, using internal compensatory treatment strategies may be advantageous
over external memory aids. This is because the internal
strategy modifies the patient’s approach to acquiring new
information and does not require that the patient transports
and/or updates an external device.
There are limitations to the current study worth mentioning. First, everyday life cognitive functioning either focused
primarily on self-report or encompassed a limited representation of daily life tasks (ie, RBMT). Future studies should
focus more on actual everyday life activities. Unfortunately,
this limitation exists in much of the cognitive rehabilitation
work to date. Second, the sample size for the booster session analyses was small and underpowered and deserves
increased attention in future research. In addition, prior history of substance use and to a lesser extent psychiatric history is characteristic of TBI. The current sample, however,
had no such history. Thus, the efficacy of the mSMT may be
different in a sample with a substance abuse and/or psychiatric
history. Additional research might address whether the intervention remains effective with a broader, less-restrictive sample of participants with TBI characteristic of the clinical
population. Given the heterogeneity of TBI, future research
will also benefit from identifying the role that individual
differences play in how patients respond to memory rehabilitation, leading to an individualized approach to cognitive rehabilitation.66
Based on widely accepted classification systems for
treatment study design,67-69 the present results provide class
I evidence supporting the efficacy of the mSMT to improve
learning and memory in TBI patients with impaired learning. A treatment effect was documented on standardized NP
tests of memory ability, tests of everyday memory abilities,
and informant report of everyday cognitive difficulties.
Thus, this study extends the evidence for efficacy of the
treatment protocol to a sample of people with TBI. Future
research should examine the optimal methodology for
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increasing the maintenance of the treatment effect over time
and development of new treatment protocols that can be
similarly successful in TBI patients.
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